# Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/biomarker-analyses-and-final-overall-survival-results-from-a-phase-iii/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Masahiro Fukuoka,Yi‐Long Wu,Sumitra Thongprasert,Patrapim Sunpaweravong,Swan-Swan Leong,Virote Sriuranpong,Tsu-Yi Chao,Kazuhiko Nakagawa,Da-Tong Chu,Nagahiro Saijo,Emma Duffield,Yuri Rukazenkov,Georgina Speake,Haiyi Jiang,Alison Armour,Ka‐Fai To,James Chih‐Hsin Yang,Tony Mok |
| Citations | 1,608 |
| DOI | 10.1200/jco.2010.33.4235 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2135192471 |
| PMID | 21670455 |
| Type | article |
| Year | 2011 |

## Paper authors

- [James Chih‐Hsin Yang](https://scholariq.org/researchers/james-chih-hsin-yang/)
- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.